Sleep Apnea is characterized by several key symptoms that can significantly impact on your quality of life. The most ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.

Abstract: A large number of obstructive sleep apnea (OSA) cases are under-diagnosed due unavailability, inconvenience or expense of sleep labs. Hence, an automated detection by applying computational ...